Drug Efficacy Study Implementation
Revision as of 17:21, 4 October 2007 by Alexandra Almonacid E. (Talk | contribs)
Drug Efficacy Study Implementation (DESI) was a program begun by the Food and Drug Administration (FDA) in the 1960s after the requirement that all drugs be efficacious as well as safe. The DESI program was intended to classify all pre-1962 drugs that were already on the market as either effective, uneffective, or needing further study.
The DESI program was a consequence of the Kefauver-Harris Drug Control Act.
See also
External links
- Drug Efficacy Study Implementation (DESI) page at the FDA's Center for Drug Evaluation and Research (CDER) website.
- The Drug Efficacy Study of the National Research Council’s Division of Medical SciencesTemplate:US-gov-stub
Navigation WikiDoc | WikiPatient | Popular pages | Recently Edited Pages | Recently Added
Pictures
There is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies
Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs
Editor Tools Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Permanent link | Maintain Pages | What Pages Link HereThere is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies
